# Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

Study · id `cardio:ct-nct02432833` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02432833](<https://clinicaltrials.gov/study/NCT02432833>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02432833

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 428 participants.

## Technical summary

Registry record NCT02432833. Randomized; no masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-01-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 428 participants (enrolled count; ClinicalTrials.gov record NCT02432833, source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)
- Start date: 2015-05 (registry gives no type) (ClinicalTrials.gov record NCT02432833, source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)
- Primary completion: 2017-01-24 (actual) (ClinicalTrials.gov record NCT02432833, source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)
- Completion: 2017-01-24 (actual) (ClinicalTrials.gov record NCT02432833, source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT02432833, source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02432833-2018-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients
- Acronym: STEADY
- Condition: End Stage Renal Disease
- Intervention (Drug): ENVARSUS®
- Intervention (Drug): PROGRAF®
- Intervention (Drug): ADVAGRAF®
- Lead sponsor: Chiesi Farmaceutici S.p.A.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Chiesi Farmaceutici S.p.A. (`cardio:org-chiesi-farmaceutici-s-p-a`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe (`cardio:pubmed-36017158`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3d98c383685c71476d6221860bb2cc2441f1a718de653b7477870798ebc8dc73
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
